One Change, Many Benefits: A Glycine-Modified Bacteriochlorin with NIR Absorption and a Type I Photochemical Mechanism for Versatile Photodynamic Therapy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252313132 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mateusz Werłos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, Jagiellonian University, 30-387 Kraków, Poland. Hauptthemen laut MEDLINE: Photochemotherapy, Porphyrins, Photosensitizing Agents, Glycine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center (NCN).
Abstract (Originalsprache)
Difluorinated sulfonamide porphyrin (F2PGly) and bacteriochlorin (F2BGly), modified by glycine residues, were synthesized and evaluated for photodynamic therapy (PDT). F₂PGly exhibits superior stability and singlet oxygen generation efficiency but features a low-intensity band in the red range (λmax = 639 nm). In contrast, F2BGly shows a favorable, red-shifted absorption spectrum (λmax = 746 nm) that aligns well with phototherapeutic window, facilitating deeper tissue penetration. Moreover, it demonstrates reasonable photostability, necessary for the efficient generation of both singlet oxygen (type II) and oxygen-centered radicals (type I mechanism) which contributes to enhanced therapeutic efficacy. Importantly, the glycine modifications in F2BGly enhance its uptake in MCF-7 cells, known for their resistance to PDT due to efflux transport proteins like LAT1, showing great potential in the cancer cell-targeted PDT. The glycine groups potentially enable F2BGly to bypass these barriers, resulting in increased intracellular accumulation and more effective Reactive Oxygen Species (ROS) generation under illumination. In vivo studies indicated promising vascular-targeted PDT results, with real-time fluorescence imaging used to monitor photosensitizer distribution prior to irradiation. These findings suggest that F2BGly is a promising photosensitizer candidate with enhanced cancer cell selectivity and photodynamic efficiency, meriting further exploration in targeted PDT applications for multiple types of cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry, Jagiellonian University, 30-387 Kraków, Poland.
- Chemistry Department, Selvita, Podole 69, 30-394 Kraków, Poland.
- Łukasiewicz Research Network, Kraków Institute of Technology, 30-418 Kraków, Poland.
- Doctoral School of Exact and Natural Sciences, Jagiellonian University, 30-348 Kraków, Poland.
ORCID-Profile: Paweł Repetowski, Janusz M Dąbrowski
Förderung
- National Science Center (NCN)
Zitieren
APA
Werłos, M., Barzowska-Gogola, A., Pucelik, B., Repetowski, P., Warszyńska, M., & Dąbrowski, J. M. (2024). One Change, Many Benefits: A Glycine-Modified Bacteriochlorin with NIR Absorption and a Type I Photochemical Mechanism for Versatile Photodynamic Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313132
Vancouver
Werłos M, Barzowska-Gogola A, Pucelik B, Repetowski P, Warszyńska M, Dąbrowski JM. One Change, Many Benefits: A Glycine-Modified Bacteriochlorin with NIR Absorption and a Type I Photochemical Mechanism for Versatile Photodynamic Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313132
BibTeX
@article{Weros2024,
author = {Werłos, Mateusz and Barzowska-Gogola, Agata and Pucelik, Barbara and Repetowski, Paweł and Warszyńska, Marta and Dąbrowski, Janusz M},
title = {One Change, Many Benefits: A Glycine-Modified Bacteriochlorin with NIR Absorption and a Type I Photochemical Mechanism for Versatile Photodynamic Therapy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252313132}
}
EUVIMED